Beta
143796

Therapeutic Potentials of Cyclic Peptides as Promising Anticancer Drugs

Article

Last updated: 01 Jan 2025

Subjects

-

Tags

Organic chemistry

Abstract

This review focuses on studying the pharmacological effect of cyclic peptides as anti-cancer drugs. There are many examples which are already used to treat cancer, either directly or in the treatment of episodes associated with cancer tumors. Goserelin acetate; is an anti-cancer drug, trade name Zoladex, is an injectable gonadotropin releasing hormone superagonist. Leuprolide acetate; is a gonadotropin-releasing hormone or luteinizing-hormone-releasing hormone analog used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer. Somatostatin, (SST), is a peptide hormone; the peptide hormone somatostatin regulates the endocrine system, affects neurotransmission and cell proliferation via interaction with G protein-coupled somatostatin receptors and inhibits the release of numerous secondary hormones. Octreotide: is a somatostatin mimic, trade name sandostatin, Octreotide is also a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. On the other hand there are many natural bioactive peptides: derived from different foods represent another source of health-enhancing or cancer fighting compounds. Different studies indicate that it is possible that many of these peptides may be released during digestion in the human stomach or during food processing from various plant and animal proteins, especially milk, soy, and fish proteins, for examples Depsipeptides and Argyrins.

DOI

10.21608/ejchem.2021.58384.3255

Keywords

Amino acids, Cyclic Peptide Derivatives, Anticancer activities, Therapeutic Peptides

Authors

First Name

Gaber

Last Name

O. Moustafa

MiddleName

-

Affiliation

Peptide Chemistry Department, Chemical Industries Research Division, National Research Centre, 12622-Dokki, Cairo, Egypt.

Email

gosman79@gmail.com

City

-

Orcid

-

Volume

64

Article Issue

4

Related Issue

22914

Issue Date

2021-04-01

Receive Date

2021-01-16

Publish Date

2021-04-01

Page Start

1,777

Page End

1,787

Print ISSN

0449-2285

Online ISSN

2357-0245

Link

https://ejchem.journals.ekb.eg/article_143796.html

Detail API

https://ejchem.journals.ekb.eg/service?article_code=143796

Order

12

Type

Review Articles

Type Code

444

Publication Type

Journal

Publication Title

Egyptian Journal of Chemistry

Publication Link

https://ejchem.journals.ekb.eg/

MainTitle

Therapeutic Potentials of Cyclic Peptides as Promising Anticancer Drugs

Details

Type

Article

Created At

22 Jan 2023